Health
Researchers identify anti-inflammatory prodrug Minnelide with potential against SARS-CoV-2 – News-Medical.Net
Using a transgenic mouse model of COVID-19, they have observed that treatment with Minnelide reduces viral load and inflammation in the lungs and improves survival….
A team of scientists from the United States has recently investigated the efficacy of an anti-inflammatory prodrug Minnelide in treating coronavirus disease 2019 (COVID-19), a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Using a transgenic mouse model of COVID-19, they have observed that treatment with Minnelide reduces viral load and inflammation in the lungs and improves survival. The study is currently available on the bioRxiv* preprint server.
Background
As…
-
Business16 hours agoThink Nvidia stock is expensive? This chart might change your mind.
-
General23 hours agoFormer Ukrainian parliament speaker Andriy Parubiy murdered in Lviv
-
Noosa News16 hours agoYoung rockers prepare to hit the stage in Eumundi
-
General22 hours agoThree dead after angry mob sets fire to parliament building in Indonesia